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Abstract
The central nervous system (CNS) contains several types of immune cells located in specific anatomic
compartments. Macrophages reside at the CNS borders surrounding the brain vessels, in leptomeningeal spaces
and the choroid plexus, where they interact with the vasculature and play immunological surveillance and
scavenging functions. We investigated the phenotypic changes and role of these macrophages in response to
acute ischemic stroke. Given that CD163 expression is a hallmark of perivascular and meningeal macrophages in
the rat and human brain, we isolated CD163+ brain macrophages by fluorescence activated cell sorting. We
obtained CD163+ cells from control rats and 16 h following transient middle cerebral artery occlusion, after
verifying that infiltration of CD163+ peripheral myeloid cells is negligible at this acute time point. Transcriptome
analysis of the sorted CD163+ cells identified ischemia-induced upregulation of the hypoxia inducible factor-1
pathway and induction of genes encoding for extracellular matrix components and leukocyte chemoattractants,
amongst others. Using a cell depletion strategy, we found that CNS border-associated macrophages participate in
granulocyte recruitment, promote the expression of vascular endothelial growth factor (VEGF), increase the
permeability of pial and cortical blood vessels, and contribute to neurological dysfunction in the acute phase of
ischemia/reperfusion. We detected VEGF expression surrounding blood vessels and in some CD163+ perivascular
macrophages in the brain tissue of ischemic stroke patients deceased one day after stroke onset. These findings
show ischemia-induced reprogramming of the gene expression profile of CD163+ macrophages that has a rapid
impact on leukocyte chemotaxis and blood-brain barrier integrity, and promotes neurological impairment in the
acute phase of stroke.
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Introduction
The central nervous system (CNS) contains different sub-
sets of myeloid cells under steady-state conditions. Micro-
glia reside in the brain parenchyma whereas macrophages
remain at the CNS borders. CNS border-associated mac-
rophages (BAMs) include cells resident in the perivascular
spaces of brain vessels, lining the meninges, and the chor-
oid plexus. BAMs carry out scavenger functions and are
fully competent to present antigen to lymphocytes [6, 12,
27, 34, 37]. BAMs derive from hematopoietic progenitors
that populate the brain at embryonic stages and are not
replaced by bone-marrow derived cells under physio-
logical conditions [18, 19]. Little is known about the func-
tion of BAMs under pathological conditions but several
lines of evidence support their involvement in the
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pathogenesis of brain diseases [13]. Perivascular macro-
phages are protective during bacterial meningitis [44], and
participate in the clearance of vascular Amyloid-β (Aβ)
deposition in mouse models of Alzheimer’s disease [23,
36, 54]. However, these cells also mediate oxidative stress
and cerebrovascular dysfunction induced by Aβ [39]. They
contribute to endothelial, neurovascular, and cognitive
dysfunction in several models of hypertension [14, 41],
and exacerbate the clinical symptoms in a model of ex-
perimental allergic encephalomyelitis [43]. A recent study
in the mouse using high-dimensional single-cell cytometry
and fate mapping identified different subsets of BAMs and
showed differential responses of BAMs compared to other
brain myeloid cell populations during aging, experimental
autoimmune encephalomyelitis, and in a model of Alzhei-
mer’s disease [37].
Ischemic stroke is a frequent disease and one of the main
causes of death and permanent disability worldwide [15].
Lack of adequate blood supply to a brain region causes brain
damage and triggers sterile inflammation and innate im-
mune responses [5, 26] that are considered as putative tar-
gets for therapeutic intervention [4]. While the responses of
microglia to ischemic stroke have been extensively studied
[33], those of BAMs remain largely unknown. Nevertheless,
BAMs might be important in cerebrovascular diseases be-
cause they are located at the interface between the blood
vessels, the brain parenchyma, and the immune system. In
humans [28] and rats [34], perivascular and meningeal mac-
rophages have been classically characterised by the expres-
sion of CD163, a membrane scavenger receptor belonging
to the cysteine-rich superfamily [31] that is involved in the
response to inflammation [10]. In this study, we investigated
the phenotype and function of CD163+ BAMs in the acute
phase of cerebral ischemia/reperfusion in rats.
Materials and methods
An extended version of the methods is available in the
Additional file 1.
Experimental brain ischemia
Focal brain ischemia was induced in adult male
Sprague-Dawley rats (280–320 g body weight) by 1-h
intraluminal occlusion of the right middle cerebral artery
(MCAo) with reperfusion. Briefly, rats were anaesthetised
with isoflurane and cortical cerebral perfusion was mea-
sured with a laser–Doppler flowmeter (PF4001 Master,
Perimed). Body temperature was maintained at 37.5 °C
during surgery with a heating blanket connected to a rec-
tal probe. The MCA was occluded with a filament (Doccol
#403912PK10Re). Rats were excluded from the study if
the mean drop in cerebral perfusion during ischemia did
not reach at least 65% of the basal value. Overall mortality
after ischemia was <10%. A neurological test on a
nine-point scale (0 = no deficit to 9 = highest handicap)
was performed at 24 h. We scored: (i) spontaneous activity
(moving/exploring = 0, moving without exploration = 1,
no moving or only when pulled by the tail = 2); (ii) circling
to the left (none = 0, circling when elevated by the tail and
pushed or pulled = 1, spontaneous circling = 2, circling
without displacement = 3); (iii) resistance to left (contralat-
eral) forepaw stretching (full resistance = 0, rats offer some
resistance but they allow stretching = 1, rats offer no re-
sistance =2), and (iv) the parachute reflex (symmetrical =
0, asymmetrical = 1, contralateral forelimb retracted = 2).
The brain was imaged 24 h after MCAo with MRI in a
7.0 T horizontal animal scanner (BioSpec, Bruker BioSpin,
Ettlingen, Germany). Brain lesions were evaluated by T2
mapping and lesion volume was measured with ImageJ.
Drug administration
Anesthetized rats (isoflurane) received an i.c.v. injection of
30 μl liposomes containing either clodronate (5 μg/μl), or
PBS as the vehicle (ClodronateLiposomes.com, Haarlem,
The Netherlands) in the left ventricle. Treatment was ran-
domly allocated according to a randomization list gener-
ated at the beginning of each set of experiments. Each
treatment received a code that did not reveal its identity.
Drug administration and all further interventions and
measurements were carried out in a blinded fashion. Is-
chemia was induced 4 days after drug administration.
Flow cytometry
Fresh brain tissue was processed with the Neural Tissue
Dissociation Kit (P) (#130–092-628, Miltenyi Biotec). A 30–
0% percoll gradient was used to remove myelin and cell deb-
ris to obtain a single-cell suspension. The pellet was washed
and stained with the life/death fixable cell staining Aqua
(ThermoFisher Scientific), and cells were immunostained
with anti-CD11b (clone OX-42, Alexa Fluor647; AbDSero-
tec or PerCP-Cy5.5; BioLegend) at 1:40 dilution, anti-CD163
(clone ED2, FITC or PE, AbdSerotec) diluted 1:20,
anti-CD45 (clone OX-1 labelled with PE-Cy7, BioLegend, or
Alexa Fluor 488 AbdSerotec) diluted 1:50, anti-granulocytes
(clone REA535, APC-Vio770, Miltenyi Biotec) diluted 1:50,
anti-CD3 (clone G4.18, PE, BD Pharmingen) diluted 1:100,
anti-CD4 (clone OX-35, BV711, BD Biosciences) diluted
1:200, anti-CD8 (clone OX-8, Vioblue, Miltenyi-Biotec) di-
luted 1:200, anti-CD161 (clone 3.2.3, APC, Biolegend) di-
luted 1:200, anti-γδTCR (clone V65, APC-Vio770,
Miltenyi-Biotec) diluted 1:100, and anti-CD25 (clone
OX-39, FITC, BD Pharmingen) diluted 1:100. We used
Flow-count Fluorospheres (Beckman-Coulter) for absolute
cell counting. Data were acquired in a BD LSRFortessa
SORP flow cytometer (BD Biosciencies) using the BD Diva
software (BD Biosciences) and were analysed with FlowJo
v10 software (FlowJo).
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Cell sorting
CD163+ macrophages and microglia were isolated from
the control rat brain and from the brain 16 h
post-ischemia using fluorescence activated cell sorting
(FACS). Briefly, the right brain hemisphere was processed
with the Neural Tissue Dissociation Kit and a percoll gra-
dient, as described above for flow cytometry, and single
cells were immunostained with CD11b and CD163.
CD11b+CD163+ cells corresponding to brain resident
macrophages and CD11b+CD163− cells were collected in
RNAse-free PBS using Aria II cell sorter (BD Biosciences).
We verified the purity of the sorted cell populations by
flow cytometry in independent experiments.
RNA extraction
RNA was extracted from samples of FACS-sorted CD163+
macrophages and FACS-sorted CD163− microglia with
PureLink™ RNA Micro Kit (#12183016, Invitrogen).
On-column DNAse step was performed to avoid genomic
DNA contamination. RNA purity was assessed by RNA Pico
Chip BioAnalyzer 2100 (Agilent). RNA was also extracted
from brain tissue samples with the PureLink™ RNA Mini Kit
(#12183018A, Invitrogen) using Trizol® Reagent (Life Tech-
nologies). In this case, we assessed the RNA quantity and
quality using a ND-1000 micro-spectrophotometer (Nano-
Drop Technologies).
qRT-PCR
Total RNA was reverse-transcribed using a mixture of
random primers (High Capacity cDNA Reverse Tran-
scription kit, Applied Biosystems). For brain tissue,
1000 ng of total RNA were reverse-transcribed and the
final product was diluted 6 times in RNAse-free water.
For RNA of sorted cells, cDNA was pre-amplified (Taq-
Man® Pre Amp Master Mix (2×) #4384266) with a pool
of TaqMan probes, and the final pre-amplified product
was diluted 20 times with tris-EDTA (TE) buffer pH 8.0
(#BP2473, Fisher Bioreagents). Quantitative real-time
RT-PCR analysis was carried out with Taqman system
(#4304437, Life Technology) using the iCycler iQTM
Multicolor Real-Time Detection System (Bio-Rad,
Hercules, CA, USA).
RNA microarray and bioinformatics
Six RNA samples obtained from sorted CD11b+CD163+
cells (from three control rats and three ischemic rats at
16 h post-ischemia) with RIN values> 9.2 were selected
for RNA microarray study with GeneChip Rat Genome
230 2.0 Array, 3’IVT Pico reagent kit (Affymetrix). The
images were processed with the Expression Console soft-
ware (Affymetrix) to check the array quality. Genes se-
lected as being differentially expressed were clustered to
look for common patterns of expression. Bioinformatics
analyses of functional and biological significance were
carried out.
Immunohistochemistry of paraffin embedded brain
sections
Rats were anesthetized with isoflurane and perfused
through the heart with saline followed by 4% PFA. Careful
extraction of the brain from the skull allowed keeping most
of the pia meningeal layer attached to the brain tissue. The
brain was kept in 4% PFA overnight at 4 °C, washed in
phosphate buffer and embedded in paraffin. Immunohisto-
chemistry was carried out in 5 μm-thick paraffin section
with the following primary antibodies: a mouse monoclonal
antibody against CD163 (clone ED2, which recognizes the
rat CD163 cell surface glycoprotein [7]) (# MCA342GA,
0.5 mg/mL, AbD Serotec, Bio-Rad) diluted 1:50, and rabbit
polyclonal antibodies against Iba-1 (# 019–19,741, 0.5 mg/
mL, Wako Chemicals USA, Inc.) diluted 1:500, and against
myeloperoxidase (MPO) (# A0398, 3.3 mg/mL, Dako), di-
luted 1:100, using the EnVisionTM Detection System; (#
K5007, Dako). Following incubation with biotinylated sec-
ondary antibodies (anti-rabbit made in goat # BA-1000; and
anti-mouse made in horse # BA2001; both from VECTOR
and used at 1:200 dilution), the immunoreaction was visual-
ized with the avidin-biotin peroxidase method (ABC, Vec-
tor, Palex Medical S.A., Sant Cugat del Vallès, Spain) and
diamenobenzidine. Cell counting was performed in a
blinded fashion.
Evans blue technique
A solution of 2% Evans blue (Sigma-Aldrich) (w/v in sa-
line) was administered i.v. (4 mL/kg of body weight)
22 h after ischemia. Two hours later, rats were anesthe-
tized and perfused with saline. We obtained images of
1-mm thick coronal sections of fresh brain that were
analysed with ImageJ software.
Western blotting
Proteins were separated by electrophoresis in 12% polya-
crilamide gels and were transferred to polyvinylidene
fluoride membranes (Immobilon-P, # IPVH00010, Milli-
poreSigma) and incubated overnight at 4 °C with a goat
polyclonal antibody anti-VEGF-A (#AF564, R&D) diluted
1:500, followed by a secondary anti-goat HRP antibody di-
luted 1:2000. β-tubulin was used as the loading control.
Post-mortem tissue of stroke patients
We studied the brain of three stroke patients (female; 63,
81 and 89 years old) deceased on day 1 after ischemic
stroke onset. Two patients had right MCA infarcts and
the third had a vertebro-basilar infarction, with a National
Institute of Health Stroke Scale (NIHSS) severity score of
20, 13, and 9, respectively. Only the first of these patients
received mechanical thrombectomy, whereas the other
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two patients did not receive any revascularization therapy.
None of the patients received tPA. The mean ± SD time
lapse from exitus to necropsy was 4.3 ± 3.2 h. Expert neu-
ropathologists obtained ischemic tissue that was embed-
ded in optimal cutting temperature (OCT) compound and
immediately frozen in liquid nitrogen for later sectioning
in a cryostat at 5 μm. The sections were processed for im-
munofluorescence using the following primary antibodies:
mouse monoclonal antibody anti-CD163 (clone EDHu-1,
1 mg/mL, # MCA1853, Serotec, Bio-Rad) diluted 1:200;
rabbit polyclonal antibody anti-VEGFA (0.9 mg/mL, #
ab46154, Abcam) diluted 1:100; and sheep polyclonal
Fig. 1 Features of the CD163+ macrophages in the acute phase of stroke. a) CD163 immunohistochemistry in paraffin brain sections 8 h after
MCAo shows CD163+ cells (brown) in perivascular and subpial spaces of the contralateral and ipsilateral hemispheres. Panels in the right are
magnifications of the squares in the adjacent panels. Images are representative of four rats. Scale bar = 10 μm. b) Flow cytometry of myeloid cells
in the control (n = 2) and ischemic brain tissue 16 h (n = 4) and 24 h (n = 7) after MCAo. The population of CD163+ cells (orange) is maintained
after ischemia, but the population of CD45hiCD11b+ cells (blue) progressively increases due to infiltration of peripheral myeloid cells to the
ischemic tissue. Microglial cells (CD45lowCD11b+) are shown in red. c) Quantification of the brain myeloid cell populations within all live cells by
flow cytometry. For each animal, we calculated the fold increase in the ischemic (ipsilateral, ipsi) hemisphere versus the contralateral (contra)
hemisphere. As expected, the ratio between the right/left hemispheres in control rats was equal to 1 (mean±SD, 0.965 ± 0.05 for CD45hiCD11b+
cells, and 1.115 ± 0.05 for CD163+ cells). The ratio ipsi/contra progressively increased after ischemia for CD45hiCD11b+ CD163− cells (*p < 0.05,
Kuskall-Wallis test followed by post-hoc Dunn’s test). In contrast, the ratio ipsi/contra for CD163+ cells was similar to controls at 16 h and the
increases at 24 h were very small and not statistically significant. Values in the graph are expressed as the mean and SD of the indicated number
of rats per group
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Fig. 2 (See legend on next page.)
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antibody anti-vWF (# ab11713, 6.8 mg/mL, Abcam) di-
luted 1:100. Sections were incubated overnight at 4 °C
with primary antibodies followed by incubation for 2 h at
room temperature with secondary antibodies (Life Tech-
nologies): Alexa Fluor-488 (# A11017 anti-mouse made in
goat, and # A21206 anti-rabbit made in donkey), Alexa
Fluor-546 (# A10036 anti-mouse made in donkey, and #
A10040 anti-rabbit made in donkey) and Alexa Flour-647
(# A21448 anti-sheep made in donkey), all diluted 1:500.
0.3% Sudan black in 70% ethanol was used to reduce tis-
sue autofluorescence. Immunoreaction controls were car-
ried out by omission of the primary antibodies, and by
substituting the primary anti-VEGFA antibody by rabbit
immunoglobulin fraction (# 0903, 20 mg/mL, Dako) di-
luted 1:2200. Sections were counterstained with 4′,6-dia-
midino-2-phenylindole (DAPI) (Invitrogen) to visualize
the cell nuclei and they were observed under a confocal
laser microscope (Zeiss LSM 880). Confocal images were
processed with ImageJ software to display the pictures.
Statistical analyses
Comparisons between two groups were carried out with
two-tailed Mann-Whitney or unpaired Student t-test after
testing for normal distribution using the Kolmogorov-Smir-
nov test. Multiple comparisons were carried out with the
non-parametric Kruskal-Wallis test followed by post-hoc
Dunn’s test. Two-way ANOVA was used to compare group
differences by treatment (clodronate vs. vehicle) and condi-
tion (ischemia vs. control). The Bonferroni’s Multiple Com-
parison tests was used for post-hoc analysis. Statistical
analyses were carried out with GraphPad Prism software.
The sample size in experiments designed to investigate the
effect of drug treatment on stroke outcome was n = 16, as
calculated using G*power 3.1 software (Düsseldorf Univer-
sity) with an estimated effect size d of 0.9, alpha level of
0.05, and statistical power of 0.8.
Results
Features of CD163+ cells in the control brain and in the
acute phase of stroke
The CD163+ rat brain cells studied in this work include
perivascular macrophages and subpial macrophages that
remained attached to the glial limitans after removing the
brain from the skull (Fig. 1a). Flow cytometry of control
brain tissue showed a higher level of CD45 expression in
CD163+ macrophages than in microglia (CD45lowCD11b+
cells) (Fig. 1b). Ischemia induces macrophage infiltration to
the brain peaking after several days [17, 47, 49, 52, 53]. We
examined the CD163+ cells and the CD45+CD11b+ myeloid
cells in the control brain tissue and the brain tissue at 16 h
and 24 h post-ischemia. Following ischemia, the population
of CD45hiCD11b+ myeloid cells progressively increased. In
contrast, the population of CD163+ cells remained similar
to controls at 16 h and showed a tendency to increase in
the ipsilateral hemisphere at 24 h (Fig. 1b,c). These results
showed that most peripheral myeloid cells infiltrating the
brain tissue in the first hours post-ischemia did not ex-
press CD163.
Ischemia-induced changes in the gene expression profile
of CD163+ BAMs
To characterize the general phenotype of CD163+ mac-
rophages and compare it with that of microglia, we iso-
lated the CD163+ cells and the CD163− microglia from
the control rat brain by fluorescence-activated cell sort-
ing (FACS) (Fig. 2a, see gates used for cell sorting in
Additional file 1: Figure S1a). We checked the purity
(mean ± SD, n rats) of the sorted cells by flow cytometry
and found that 92.0 ± 4.2% (n = 4) of the sorted cells
were CD11b+CD163+ cells. We also verified by flow cy-
tometry that the CD11b+CD163− cell population was
enriched in CD45dimCD11b+ microglia (92.9 ± 2.4%, n =
2). We then performed additional cell sorting experi-
ments for RNA extraction and gene expression studies
(Fig. 2a). By qRT-PCR we detected Cd163 mRNA ex-
pression in the sorted CD163+ population but not in the
sorted microglia, as expected, whereas the expression of
Aif1 (Iba-1) was higher in microglia than in the CD163+
cells, and Siglec1 (CD169) expression was detected in
CD163+ cells but not in microglia (Fig. 2b).
We aimed to investigate whether ischemia changed the
gene expression profile of the resident CD163+ macro-
phages. We isolated the CD11b+CD163+ cells by FACS as
above in groups of control non-ischemic rats and rats
(See figure on previous page.)
Fig. 2 Gene expression profile of CD163+ macrophages after brain ischemia. a) We isolated CD11b+CD163+ BAMs and CD11b+ CD163− microglia
by FACS from control rat brain and obtained RNA for gene expression analysis. Colors for cells in the drawings are arbitrary. b) By qRT-PCR we
validated that sorted macrophages, but not sorted microglial cells, express Cd163. The expression of Aif1 (Iba-1) is higher in microglia than
macrophages, whereas the expression of Siglec1 (CD169) is lower in microglia. Values are expressed as fold versus the mean value of CD163+
macrophages and are the mean±SD of n = 3–6 samples per group. **p < 0.01, *p < 0.05, two-tailed Mann-Whitney test. c) RNA was extracted from
CD163+ cells immunosorted from the control and the ischemic rat brain at 16 h of reperfusion (n = 3 per group) to study ischemia-induced
changes in gene expression profile using Affymetrix microarrays. The global heat map, where each lane represents macropahge gene expression
from the brain of different control or ischemic rats, shows results of the microarray analysis with∣logFC∣> 2 and FDR < 0.01. d) Top diseases/
functions associated to gene expression profile changes were obtained with ingenuity pathway analysis (IPA) gene ontology algorithms showing
category scores. The minimum significance level (−log(p-value)) from Fisher’s exact test is indicated by the threshold (arrow). Inflammatory and
immune functions are highlighted suggesting the involvement of CD163+ macrophages in such responses after brain ischemia
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Fig. 3 CD163+ BAMs upregulate the expression of leukocyte chemoattractants after ischemia. a) Heatmap showing the profile expression of
upregulated (pink) and downregulated (green) genes in the GO term Leukocyte chemotaxis. A set of genes upregulated after ischemia is
highlighted. b) Heatmap of genes of the IPA category Recruitment of neutrophils. Some of these genes (arrows) were later analyzed by qRT-PCR in
RNA of cells sorted from a different set of rats. c) In a different group of controls (n = 3) and ischemic rats (n = 5) (16 h of reperfusion), we sorted
CD163+ BAMs, extracted RNA and carried out qRT-PCR to validate up-regulation of some of the genes previously identified in the microarray.
Values are expressed as fold vs. the mean value of control CD163+ cells and are shown as the mean±SD. d) Gene expression as assessed by qRT-
PCR in sorted CD163+ BAMs and sorted microglia (n = 3 controls and 5 ischemic rats per each cell type). All values are normalized versus the
mean value of controls and are represented as the mean±SD. Generally, induction of gene expression after ischemia is similar or lower in BAMs
than microglia, with the exception of some genes like Ccl17 that was induced after ischemia in BAMs but not microglia. Two-way ANOVA
followed by the Bonferroni test, *p < 0.05 and **p < 0.01 microglia vs. BAMs
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subjected to ischemia plus 16 h of reperfusion (Additional
file 1: Figure S1b). We chose to study this time point after is-
chemia given that myeloid cell infiltration was still very mild
and the majority of CD163+ cells were resident macrophages
(Fig. 1b,c). We obtained RNA from the sorted cells, and
processed it with Affymetrix microarrays. Unsupervised
clustering analysis showed that the samples clustered ac-
cording to the groups (Additional file 1: Figure S2a), and
principal component analysis precisely separated the ische-
mic from the control samples (Additional file 1: Figure S2b).
We selected the genes showing statistically significant differ-
ences between ischemic and control groups (adjusted
p-value< 0.01) and filtered for∣logFC∣> 2. According to the
above criteria, the expression of 1493 genes was
up-regulated whereas the expression of 594 genes was
down-regulated in CD163+ macrophages after ischemia, as
graphically illustrated in the volcano plot (Additional file 1:
Figure S2c). The global heat map illustrates differentially
expressed genes in these groups (Fig. 2c). The top 25
up-regulated genes (Additional file 1: Table S1) included
genes related to the extracellular matrix, such as Vcan (ver-
sican), Sdc1 (syndecan), Fn1 (fibronectin-1), Spp1 (osteo-
pontin), Sema3c (semaphorin 3c), Mmp7 (matrix
metalloproteinase 7, MMP-7), and Mmp14 (MMP-14) sup-
porting a role of CD163+ macrophages in extracellular
matrix remodelling. Also, we detected up-regulation of
genes involved in nicotinamide adenine dinucleotide me-
tabolism (Cd38), and inflammatory and immune responses,
like Tspo, Cd8a, and Itgax (CD11c). The sorted CD163+
cells expressed genes recently identified in BAMs of the
mouse brain, such as Mrc1 (CD206), Mertk, Adgre1
(F4.80), Fcgr3a (CD16), C5ar1 (CD88), Lyve1, RT1-ba
(MHC class II antigen), Cd44, Cd38 [37], and Tmem119,
Csf1r, and Cxcr4 [29]. However, the expression of most of
these genes did not significantly change after ischemia, with
the exception of increased expression of Cd38 (Additional
file 1: Figure S3A) and Cd44 (Fig. 3b). Neither control nor
ischemic CD163+ BAMs showed expression of genes en-
coding for typical microglial proteins, like Sall1. Among the
top genes down-regulated after ischemia we found the
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
(AMPA) glutamate receptor Gria2, genes related to subcel-
lular organization, like Syne2 and Fam65b, and genes of the
extracellular matrix, such as Adam23, certain growth factor
receptors, like Egfr, and genes related to immune responses
particularly associated to inhibition of leukocyte activation,
such as Siglec5 (Additional file 1: Table S2).
The analysis of biological significance was based on en-
richment analysis on different annotation databases to
highlight biological categories in which the selected genes
appear to be over-represented after brain ischemia. The
GO analysis identified over-representation, enriched
KEGG entities and clusters for terms related to acute in-
flammatory response, cytokine activity, chemokine activity,
response to hypoxia, extracellular space, extracellular
matrix, metalloproteinases, collagen degradation, blood
vessel remodelling, angiogenesis, and response to oxidative
stress, amongst others (see Additional file 1: Figure S3 for
heat maps of genes in GO-terms representative of the in-
flammatory response). Down-regulated KEGG pathways
included: ATPase, Ca++ transporting; ATPase, Na+/K+
transporting; Cd7 molecule; KIT ligand; beta-2-adrenergic
receptor; and epidermal growth factor receptor (Egfr) path-
way. Ingenuity Pathway Analysis (IPA) identified top ca-
nonical pathways (Additional file 1: Figure S4A) and top
associated disease/functions (Fig. 2d). Amongst the highly
up-regulated pathways, hypoxia inducible factor-1 (HIF-1)
signalling highlighted the response to ischemic conditions
(Additional file 1: Figure S4), illustrated by up-regulation
of Hif1a and vascular endothelial growth factor-A (Vegfa)
genes (Fig. 3a, Additional file 1: Figure S3). The term lipo-
polysaccharide (LPS) was amongst the top upstream regu-
lators, suggesting acquisition of pro-inflammatory features
reminiscent of the response to LPS. However,
ischemia-induced CD163+ macrophage activation showed
a distinctive metabolic and inflammatory signature. For
instance, regarding arginine metabolism [38], inducible ni-
tric oxide synthase (iNOS, Nos2) was not overrepresented
whereas arginase-1 (Arg1) was one of the top up-regulated
genes (Additional file 1: Table S1). This effect is expected
to suppress excessive nitric oxide production and promote
L-arginine consumption impairing lymphocyte activation
in response to antigen [3, 8].
Ischemia induces the expression of leukocyte
chemoattractants in CD163+ BAMs
The above gene pathway analyses in CD163+ macrophages
highlighted the response to wounding, inflammation, and
(See figure on previous page.)
Fig. 4 Treatment with clodronate liposomes depleted BAMs in control and ischemic rats. a) Flow cytometry plots of CD11b+CD163+ cells in the
brain of control rats treated i.c.v. with either vehicle liposomes (V) or clodronate liposomes (CL) 5 days before the analysis. b) CL reduced the
numbers of brain CD11b+CD163+ cells (*p < 0.05, n = 4 per group). c) Rats received CL or V in the left ventricle 4 days before occlusion of the
right MCA and the brain was analyzed by flow cytometry 1 day after ischemia. d) Flow cytometry analysis of CD11b+ CD163+ cells of the
ischemic hemisphere (n = 12 V; n = 11 CL) and the corresponding hemisphere of control rats (n = 11 V; n = 9 CL) and shows reduction after
treatment with CL versus V in both groups. *** p < 0.001, two-way ANOVA by treatment and condition. e) Immunohistochemistry and cell
counting in brain shows reduced numbers of CD163+ cells in the contralateral and ipsilateral (infarcted core) cortical and subcortical regions of
the CL group (n = 12) compared to the V group (n = 10). *** p < 0.001, ** p < 0.01. Scale bar: 20 μm
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chemotaxis after ischemia. A heatmap representation is
shown for the GO term Leukocyte chemotaxis where sev-
eral genes up-regulated by ischemia are detailed (Fig. 3a).
The IPA analysis identified over-representation of the
term Neutrophil recruitment (Fig. 3b). The analyses
showed up-regulation of genes such as Spp1, interleukin-6
(Il6), C-X-C motif chemokine ligands 14 (Cxcl14), S1008a,
and L-selectin (Sell), amongst others. Ischemia also
up-regulated genes encoding for chemokines involved in
recruiting T helper type 2 (Th2) lymphocytes, like Ccl22
and Ccl17 [56] (Fig. 3, Additional file 1: Table S1). For val-
idation purposes, some of the up-regulated genes related
to leukocyte chemotaxis were studied by qRT-PCR using
RNA of CD163+ macrophages sorted from different
groups of control and ischemic rats 16 h post-ischemia
(Fig. 3c). We compared the expression of these genes in
FACS-sorted CD11b+CD163+ cells versus sorted
CD11b+CD163− cells enriched in microglia (Additional
file 1: Figure S1). CD163+ macrophages seemed to work in
consonance with microglia to promote leukocyte re-
cruitment to the ischemic brain since most of the
genes that we studied by qRT-PCR showed similar
(e.g Spp1, C1qbp) or weaker (e.g. Sell) expression in
CD163+ macrophages compared to microglia. How-
ever, ischemia up-regulated certain genes, such as
Ccl17, preferentially in CD163+ macrophages (Fig.
3d). Altogether, these results suggested the possibility
that CD163+ macrophages participated in the recruit-
ment of leukocytes after brain ischemia.
Selective depletion of BAMs but not microglia in control
and ischemic brain
To obtain functional information on the role of BAMs in
the acute phase of stroke, we carried out loss-of-function ex-
periments by intracerebroventricular (i.c.v.) administration
of liposomes containing clodronate [14, 23, 42, 43]. Macro-
phages scavenge the liposomes and the intracellular accu-
mulation of the toxin clodronate induces macrophage cell
death [46, 55]. Liposomes containing either clodronate or
vehicle (PBS) were administered in the left ventricle and the
brain was analyzed 5 days later. Flow cytometry studies of
the brain cells showed that clodronate liposomes induced a
strong reduction (65–70%) of the CD163+ population in
both hemispheres (Fig. 4a,b). We then checked that CD163+
cell depletion was maintained after brain ischemia. We oc-
cluded the right MCA four days after administration of clo-
dronate or vehicle liposomes to the left ventricle and
studied the brain tissue 24 h post-ischemia (Fig. 4c).
CD163+ cells were also reduced in the ischemic tissue after
clodronate treatment, as assessed by flow cytometry (Fig.
4d). Immunohistochemistry (Fig. 4e) showed depletion of
CD163+ macrophages located in the perivascular spaces and
on the glia limitans under the pia matter. Of note, we veri-
fied that i.c.v. clodronate liposome treatment did not signifi-
cantly affect the number of parenchymal microglia
compared to the vehicle group in the control and ischemic
brain tissue, as shown by immunohistochemistry (Iba1+)
(Additional file 1: Figure S5a), and flow cytometry
(CD45dimCD11b+) (Additional file 1: Figure S5b). In both
Fig. 5 Depletion of BAMs does not reduce infarct volume but attenuates the neurological deficit. a T2w MRI 24 h post-ischemia of representative
rats per treatment group, i.e. clodronate (CL, n = 16) or vehicle (V, n = 17) liposomes. b Ischemia induced a similar drop of cortical perfusion (CBF)
during MCAo, as assessed by laser Doppler, in both groups. The neurological score shows a small but significant improvement in the CL group.
(Mann-Whitney test, * p = 0.046) There are no differences between groups in total infarct volume (b), as well as the volume of infarcted cortical
and subcortical regions (not shown), as assessed by T2w MRI. Treatment, ischemia, neurological evaluation, MRI, and infarct volume measures
were carried out in a blinded fashion
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hemispheres of the clodronate group we observed the
presence of CD163− Iba1+ perivascular cells (Fig. 4e,
Additional file 1: Figure S5b) that might correspond to
peripheral myeloid cells. The effect of i.c.v. administra-
tion of clodronate was local and it did not modify blood
cell counts (Additional file 1: Figure S6).
BAM depletion ameliorated the stroke-induced
neurological dysfunction
To find out whether BAM depletion affected the extent of
brain damage we measured the size of the brain lesion and
assessed the neurological function 24 h post-ischemia in
rats treated with clodronate or vehicle liposomes, as
Fig. 6 Effects of BAM depletion on leukocyte infiltration after brain ischemia. Rats received clodronate (CL) or vehicle (V) liposomes in the left
ventricle 4 days before occlusion of the right middle cerebral artery and the brain was analyzed 1 day after ischemia. a) mRNA was extracted
from the contralateral (control) and ipsilateral (ischemic) brain hemispheres of rats treated with V (n = 7) or CL (n = 6) for qRT-PCR analysis. Values
are expressed as fold versus the mean value in the control V group. CL does not reduce leukocyte chemoattractants that were upregulated by
ischemia in CD163+ macrophages (see Fig. 3), such as Spp1, C1qbp, Il6, and Ccl17. b) Flow cytometry analysis of the brain hemisphere of control
rats (n = 11 vehicle, V; n = 9 CL) and ischemic rats (n = 12 V; n = 11 CL) illustrates leukocyte infiltration in the ischemic group. c) Depletion of
CD163+ macrophages (CL group) reduces the percentage of REA535+ granulocytes in the infiltrating myeloid cell population
(CD45hiCD11b+) (*p = 0.039)
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above. One-hour ischemia induced large brain lesions and
BAM depletion did not cause a major effect in the volume
of infarction (Fig. 5). However, rats depleted of BAMs
showed a mild but significant improvement of the neuro-
logical score (Fig. 5), suggesting that BAM activity has
negative consequences for the neurological status in the
acute phase of stroke.
BAM depletion alters leukocyte recruitment after brain
ischemia
We then investigated by qRT-PCR whether depletion of
BAMs altered the RNA expression of cytokines and chemo-
kines in the brain tissue 24 h after ischemia. The brain of rats
treated with clodronate liposomes did not show a significant
reduction in the mRNA expression of the leukocyte chemoat-
tractants and chemokines that we examined (Fig. 6a). This re-
sult is compatible with ischemia-induced expression of these
genes in other cells in addition to CD163+ macrophages, in-
cluding microglia and potentially astrocytes or other neural
cells. In spite of this, depletion of CD163+ cells reduced the
percentage of infiltrating REA535+ granulocytes in the ische-
mic hemisphere, as determined by flow cytometry (Fig. 6b,c)
whereas the numbers of other leukocytes were not affected
(Additional file 1: Figure S7). To validate this finding, we car-
ried out immunohistochemistry with anti-myeloperoxidase
antibodies in an independent group of rats. Blind cell count-
ing showed less infiltrating granulocytes after BAM depletion,
particularly in cortical regions (Fig. 7a). To further investigate
possible regional differences we carried out a second flow cy-
tometry study in an independent group of ischemic rats
where we dissected out cortical and subcortical regions and
analysed them separately. BAM depletion reduced REA535+
granulocyte numbers in the ischemic cortex, whereas subcor-
tical regions only showed a non-significant trend (Fig. 7b). In
contrast to the effect on granulocyte recruitment, BAM de-
pletion did not significantly modify the numbers of T cells,
NK cells, or myeloid mononuclear cells infiltrating the ische-
mic tissue (Additional file 1: Figure S8).
BAMs increase cortical vascular permeability 24 h after
ischemia
The microarray analysis of sorted CD163+ macrophages
identified over-representation of genes involved in the
post-ischemic response to hypoxia, such as the
HIF-target gene Vegfa (Fig. 3a, Additional file 1: Figure
S3a). BAM depletion reduced the expression of Vegfa
mRNA in the cerebral cortex 24 h post-ischemia,
whereas this effect was milder in subcortical regions
(Fig. 8a). Ischemia induced the expression of VEGF164
protein (Fig. 8b), a VEGF-A isoform (similar to human
VEGF165) that is secreted and has the capacity to bind to
the extracellular matrix [45]. In agreement with the
mRNA results, BAM depletion reduced the cortical ex-
pression of VEGF164 (Fig. 8b).
Given that hypoxia-induced VEGF in the brain pro-
duces acute vascular leakage [48], we studied whether
BAM depletion affected vascular permeability. Not-
ably, ischemia-induced Evans blue extravasation from
the ipsilateral pial vessels and cortex was minimal in
rats depleted of BAMs (Fig. 8c), which showed a re-
duced volume of tissue with Evans blue extravasation
in the cortex but not in subcortical regions. These re-
sults suggest that depletion of BAMs prevented
ischemia-induced leakage of pial and cortical vessels.
We then investigated whether these findings might
be relevant to acute ischemic stroke in humans. To
this end, we studied CD163+ macrophages in
post-mortem brain tissue of three patients with fatal
ischemic stroke deceased 24 h after symptom onset.
VEGF immunoreaction was detected surrounding
blood vessels and we found some CD163+ perivascu-
lar macrophages positive for VEGF (Fig. 9). We ob-
served that VEGF immunoreactivity was more
prominent in the two patients that did not receive
any revascularization therapy than in the patient that
received mechanical thrombectomy. This effect is
likely attributable to persistent ischemic conditions in
the former. The described perivascular VEGF immu-
noreaction was mainly found at the periphery of the
infarcted core. In the infarcted core, we also observed
VEGF immunoreactivity in parenchymal CD163− cells
with a pattern of expression that varied across the tis-
sue and between patients. Altogether, these results are
compatible with the possibility that human CD163+
perivascular macrophages secreted VEGF in acute is-
chemic stroke.
(See figure on previous page.)
Fig. 7 Depletion of BAMs reduces granulocyte infiltration in the ischemic cortex. Rats received clodronate (CL) or vehicle (V) liposomes in the left
ventricle 4 days before occlusion of the right middle cerebral artery and the brain was analyzed 1 day after ischemia. a) Myeloperoxidase (MPO)
immunohistochemistry (brown, arrows) of the core of infarction in paraffin sections (counterstained with hematoxylin in blue) of ischemic rats
treated with V or CL. Scale bar: 20 μm. Blind cell counting showed that CL (n = 12) reduces the numbers of MPO+ cells in the ischemic cortex
compared to the V (n = 8) (*p = 0.05), but differences in subcortical regions were not statistically significant (CL n = 12, V n = 10, p = 0.12). b) An
independent group of rats treated with V or CL was studied by flow cytometry 24 h postischemia after dissection of cortical and subcortical brain
regions. The numbers of REA535+ granulocytes was determined. Values are expressed as number of cells per gram of brain tissue. The number of
REA535+ cells decreased in both regions after BAM depletion. However, differences between treatment groups were statistically significant in
cortical regions (*p = 0.038), whereas only a trend was observed in subcortical regions (p = 0.085)
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Discussion
BAMs are players at the interface between the nervous
system and the immune system [6, 12, 27, 29, 34, 37,
53]. However, the precise functions of these cells under
pathological conditions remain largely unknown. This
study provides evidence for a role of BAMs increasing
vascular permeability, facilitating granulocyte recruit-
ment, and contributing to neurological dysfunction in
the acute phase of ischemic stroke. BAMs express typ-
ical myeloid cell markers like microglia but their differ-
ential phenotypic features were less known until recently
published studies provided an extensive description of
the phenotype of BAMs in the mouse brain [29, 37]. We
verified that rat CD163+ BAMs expressed genes encod-
ing for proteins identified in these latter works. How-
ever, the expression of most of these BAM genes did not
significantly change 16 h post-ischemia versus controls,
with the exception of increased expression of Cd38 and
Cd44. Although CD44 expression was previously consid-
ered as a marker of brain infiltrating cells [29], we de-
tected the expression of Cd44 in CD163+ BAMs
obtained from the control rat brain, in agreement with
the finding of CD44+ BAMs in the control mouse brain
[37]. Furthermore, the expression of Cd44 increased
after ischemia, as described for CD44 expression in
mouse BAMs in EAE [37]. In addition, we found that rat
CD163+ BAMs express Siglec1 (CD169) and low levels
of Aif1 (Iba-1), in contrast to microglial cells that do not
express Siglec1 and express comparatively higher levels
of Aif1.
Brain ischemia causes necrotic neuronal cell death with
release of danger signals that activate the microglia [26],
but the response of BAMs is currently unknown. We found
that these cells respond to ischemic conditions by showing
changes in the gene expression profile enabling adaptation
to hypoxia and acquisition of novel cellular functions in-
volved in extracellular matrix-vascular interactions and in-
flammatory responses. BAMs upregulated the expression of
genes regulating neutrophil chemotaxis as part of the re-
programming process induced by ischemia. The anatomic
location of these cells confers them the capacity to partici-
pate in the communication network between the brain en-
vironment and the vasculature. Brain ischemia induces
neutrophil extravasation from leptomeningeal vessels and
neutrophil accumulation in perivascular spaces of the af-
fected brain region [9, 40]. Our study suggests that CD163+
macrophages attract granulocytes to the leptomeningeal
and perivascular spaces in response to brain ischemia.
These findings are in consonance with a study showing that
perivascular macrophage depletion reduced brain neutro-
phil infiltration in a model of vesicular stomatitis viral in-
fection [51]. Furthermore, perivascular macrophages
mediate neutrophil recruitment during bacterial skin infec-
tion [1]. Other works reported the involvement of mono-
nuclear cells in neutrophil attraction. For instance, specific
subsets of monocytes are key regulators of neutrophil ex-
travasation in the lung [30].
Functional analysis of genes over-represented in
CD163+ BAMs after brain ischemia versus controls
highlighted the activation of neovascularization pro-
cesses and the HIF-1 pathway. This finding is consistent
with the observed up-regulation of the HIF-1α target
gene Vegfa, a potent modulator of angiogenesis [2, 32]
and regulator of the cellular redox status [11]. We ob-
served the expression of VEGF in the post-mortem hu-
man brain tissue of stroke patients deceased 24 h after
stroke onset, and detected VEGF surrounding some
brain vessels and CD163+ perivascular macrophages,
suggesting that the findings in rats might be valid in
acute ischemic stroke patients. Acute production of
VEGF is associated with increases in vascular permeabil-
ity [48]. In our study, BAM depletion in the rats de-
creased the ischemia-induced expression of Vegfa
mRNA and the secreted protein isoform, VEGF164, in
the cerebral cortex. Furthermore, BAM depletion re-
duced Evans blue extravasation from pial and cortical
vessels, whereas these effects were less marked in sub-
cortical regions. We argue that the greater cortical effect
might be due to the activity of subpial macrophages in-
creasing the permeability of pial vessels in the acute
(See figure on previous page.)
Fig. 8 Depletion of BAMs attenuates ischemia-induced pial and cortical vascular permeability. BAMs were depleted by i.c.v. administration of
clodronate liposomes (CL) 4 days prior to ischemia. For treatment control, rats received vehicle liposomes (V). a) Vegfa mRNA was studied in
cortical and subcortical regions of the ipsilateral (ipsi, ischemic) and the contralateral (contra) brain hemispheres. Ischemia-induced expression of
Vegfa mRNA at 24 h is attenuated in the cortex of the CL rats versus the V rats (n = 6 per group) (Mann Whitney test, p = 0.041). b) Western
blotting of cortical and subcortical brain tissue (ipsilateral) 24 h post-ischemia shows the VEGF164 isoform of VEGF-A detected as two bands
corresponding to the homodimeric and monomeric forms at approximately 54 kDa and 24 kDa. Quantification of signal intensity of the 54-kDa
band shows reduced expression in the cortex of rats receiving CL vs. rats receiving V (n = 6 per group) (Mann-Whitney test, **p = 0.002). c)
Ischemia increases the permeability of pial vessels (arrows), as assessed by Evans blue extravasation 24 h post-ischemia, and BAM depletion
attenuates the effect. Images of one representative coronal brain section per rat of each treatment group show Evans blue extravasation in the
ipsilateral hemisphere. Rats receiving clodronate show negligible Evans blue in the cortex (arrows in the schematic representation at the right
hand side). The volume of tissue showing Evans blue extravasation is reduced in the cortex, but not in subcortical zones, of the CL group (n = 8)
versus the V group (n = 7) (Mann-Whitney test, *p = 0.014)
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phase of stroke. While we were preparing this manu-
script, a study reported pathogenic actions of CD163+
macrophages in atherosclerosis where these cells showed
activation of HIF1α and VEGF expression and increased
vascular permeability and inflammatory cell recruitment
[20]. Interestingly, perivascular macrophages are involved
in maintaining vascular barrier function in the periphery
under physiological conditions [21, 24]. Here we show that
an ischemic stroke challenge changes the homeostatic
function of CD163+ macrophages by inducing cellular acti-
vation of the HIF pathway and generation of VEGF and in-
flammatory mediators. This effect in the very acute phase
of stroke does not exclude putative vasculoprotective effects
of perivascular macrophages in chronic phases after stroke.
Our study did not find any differences in infarct vol-
ume 24 h post-ischemia in rats depleted of BAMs, in
spite that they showed reduced granulocytes in the is-
chemic brain. Previous studies reported reduced infarct
Fig. 9 CD163+ macrophages and neighboring vessels express VEGF in human ischemic stroke. VEGF around the vessels and in surrounding
CD163+ macrophages in human ischemic stroke. Immunofluorescence staining of post-mortem brain tissue of patients deceased 24 h after
ischemic stroke (n = 3). Confocal microscope images show CD163+ macrophages (red in a-c, green in d-e), vascular endothelium (von Willebrand
factor, vWF; blue), and cell nuclei (white) that are stained with DAPI. The presence of VEGF immunoreactivity (green in a-c, red in d-e) is observed
surrounding the endothelial layer of blood vessels and in CD163+ macrophages. Images in c and e are magnifications of the indicated part of b
and d, respectively. Orthogonal projections show co-localization of VEGF and CD163 staining in some cells. The arrows point to CD163+
perivascular macrophages positive for VEGF. Scale bar: 10 μm
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volume after ischemia/reperfusion in rats depleted of
neutrophils [35]. However, the effects were not entirely
reproduced in a model of severe ischemia/reperfusion in
rats [22], or in a model of ischemia/reperfusion plus
thrombolytic treatment in spontaneous hypertensive rats
where only one out of two different neutrophil depletion
strategies reduced the lesion size [16]. Also, neutrophil
depletion reduced infarct size in hyperlipidemic ApoE−/−
mice but not in normolipidemic wild-type mice [25].
Therefore, it was unlikely that the moderate reduction of
granulocyte recruitment induced by BAM depletion in
our model of severe ischemia/reperfusion was sufficient
to cause major differences in the size of the severe brain
lesion induced by our ischemia model. Nevertheless, we
found some improvement of the neurological function
in the absence of BAMs that was attributable to attenu-
ated granulocyte recruitment and preservation of pial
and cortical vascular integrity after ischemia.
A limitation of our study is that it only addressed the
function of BAMs in the acute phase of stroke. We re-
stricted our study to the first hours after stroke to avoid
the putative confounding effect of massive macrophage in-
filtration that takes place in the days that follow stroke [5,
17, 47, 49, 52]. Moreover, our BAM depleting strategy is
transient and repopulation of these cells by peripheral
macrophages could follow at later time points. Long-term
studies using different experimental approaches are re-
quired to understand the consequences of BAM activity
for the evolution of the brain lesion and the repair pro-
cesses, particularly regarding extracellular matrix and vas-
cular remodelling. Another limitation is that we could not
separate perivascular from subpial macrophages since all
of them express CD163 in the rat brain. Depleting the
CD163+ macrophage population had more effects in cor-
tical rather than in subcortical regions after ischemia. We
suspect that subpial macrophages may play a role by pro-
ducing VEGF and regulating vascular permeability and ex-
travasation of granulocytes from pial vessels. These effects
could exacerbate the brain lesion by impairing the integ-
rity of the collateral circulation [50]. Finally, we conducted
our experimental study in young male rats, while stroke
mainly affects old people of both sexes. Studies in aged
animals and females are required to find our whether
BAMs show a similar response in these conditions.
Conclusions
In summary, this study provides evidence for a role of
BAMs in granulocyte chemoattraction and vascular per-
meability following acute ischemic stroke. The study also
suggests that targeting these potentially negative re-
sponses of brain resident macrophage might help to pre-
serve cortical blood supply and improve the neurological
function in the acute phase of cerebral ischemia/
reperfusion.
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